2 assets in Primary Lymphoma Of The Conjunctiva

Therapeutic assets addressing Primary Lymphoma Of The Conjunctiva, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nemtabrutinib Primary Lymphoma Of The Conjunctiva	City of Hope Medical Center	P2	CCC (53)
Rituximab Primary Lymphoma Of The Conjunctiva	City of Hope Medical Center	P2	CCC (53)